Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence